MAPT and Cognitive impairment: Low Aβ 1-42 and high tau is qualified as a predictive (prognostic?) marker for an evolution to dementia in patients diagnosed with mild cognitive impairment. The ratio is discussed but not qualified, no cut-off values are qualified.